Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Victory Square Technologies Inc ( (TSE:VST) ) has issued an update.
Victory Square Technologies reported significant achievements in 2024, including a notable net income of $10.7M in Q3 and an estimated net asset value of $127.5M. The company made strides in digital health, expanding its VSDHOne platform across the U.S., while Hydreight Technologies launched a $10M Health Accelerator. Additionally, Insu Therapeutics is developing oral insulin delivery technology for the $118B diabetes market, and Stardust Solar expanded its renewable energy initiatives. Looking forward, Victory Square’s strategy for 2025 emphasizes scaling digital health solutions, accelerating portfolio growth, and enhancing shareholder value, capitalizing on the ongoing transformation in the healthcare sector.
More about Victory Square Technologies Inc
Victory Square Technologies Inc. is a venture builder offering investors access to a diversified portfolio of over 25 high-growth companies in sectors such as digital health, renewable energy, and artificial intelligence. The company focuses on identifying and scaling transformative technologies to drive long-term shareholder value.
YTD Price Performance: 46.77%
Average Trading Volume: 181,840
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$45.3M
See more insights into VST stock on TipRanks’ Stock Analysis page.
